Table 1

Baseline characteristics of individuals with mitral regurgitation (N = 104 851)

No MRMild (1+) MRModerate (2+) MRModerate to severe (3+) MRSevere (4+) MR
(N = 4431)(N = 87 908)(N = 10 130)(N = 1839)(N = 543)
Age (years)57.2 ± 17.957.8 ± 18.072.7 ± 14.674.1 ± 14.571.3 ± 15.6
Female, n (%)2166 (48.9)45457 (51.7)5432 (53.6)1021 (55.5)277 (51.0)
Bedside study, n (%)1392 (31.4)19079 (21.7)3326 (36.4)670 (36.4)233 (42.9)
Inpatient study, n (%)2373 (53.6)37381 (42.5)6323 (62.4)1295 (70.4)388 (71.5)
Suboptimal image quality, n (%)1016 (22.9)13467 (15.3)1599 (15.8)217 (11.8)57 (10.5)
Systolic blood pressure (mmHg)127.1 ± 34.8127.6 ± 28.7129.9 ± 30.4127.1 ± 49.1122.6 ± 54.1
Diastolic blood pressure (mmHg)73.2 ± 36.673.9 ± 32.472.1 ± 33.571.6 ± 39.169.1 ± 23.1
Heart rate (beats per minute)79.1 ± 19.874.4 ± 20.376.0 ± 23.380.1 ± 29.582.1 ± 31.9
Mitral valve prolapse, n (%)73 (1.7)1509 (1.7)428 (4.2)227 (12.3)167 (30.8)
Left atrial size (cm)
 AP3.7 ± 0.73.8 ± 0.74.4 ± 0.84.7 ± 0.84.8 ± 0.9
 SI5.0 ± 0.85.0 ± 0.85.7 ± 0.96.0 ± 1.06.2 ± 1.0
Right atrial length (cm)4.8 ± 0.74.9 ± 0.75.4 ± 0.95.6 ± 1.05.6 ± 1.1
Left ventricular dimension (cm)
 End diastole4.5 ± 0.64.6 ± 0.64.9 ± 0.95.3 ± 1.05.6 ± 1.0
 End systole2.8 ± 0.62.9 ± 0.63.3 ± 1.03.8 ± 1.24.0 ± 1.3
Left ventricular ejection fraction (%)57.2 ± 11.955.9 ± 12.546.2 ± 17.340.3 ± 20.041.1 ± 20.4
Right ventricular diastolic diameter (cm)3.3 ± 0.73.4 ± 0.83.7 ± 0.93.9 ± 0.94.0 ± 1.0
Peak transaortic velocity (m/s)1.5 ± 0.51.5 ± 0.51.8 ± 0.91.9 ± 1.11.8 ± 0.9
Transmitral peak E-wave velocity (m/s)0.8 ± 0.30.8 ± 0.31.0 ± 0.31.2 ± 0.41.3 ± 0.3
Transmitral peak A-wave velocity (m/s)0.8 ± 0.40.8 ± 0.30.8 ± 0.40.8 ± 0.50.8 ± 0.4
Transmitral E/A ratio1.1 ± 0.51.2 ± 0.51.3 ± 0.81.7 ± 0.91.9 ± 1.0
E/e′ ratio8.7 ± 3.69.1 ± 3.813.6 ± 6.415.9 ± 7.218.8 ± 9.7
Estimated peak tricuspid regurgitant pressure (mmHg)25.1 ± 10.025.9 ± 9.334.3 ± 11.839.7 ± 13.541.7 ± 14.2
No MRMild (1+) MRModerate (2+) MRModerate to severe (3+) MRSevere (4+) MR
(N = 4431)(N = 87 908)(N = 10 130)(N = 1839)(N = 543)
Age (years)57.2 ± 17.957.8 ± 18.072.7 ± 14.674.1 ± 14.571.3 ± 15.6
Female, n (%)2166 (48.9)45457 (51.7)5432 (53.6)1021 (55.5)277 (51.0)
Bedside study, n (%)1392 (31.4)19079 (21.7)3326 (36.4)670 (36.4)233 (42.9)
Inpatient study, n (%)2373 (53.6)37381 (42.5)6323 (62.4)1295 (70.4)388 (71.5)
Suboptimal image quality, n (%)1016 (22.9)13467 (15.3)1599 (15.8)217 (11.8)57 (10.5)
Systolic blood pressure (mmHg)127.1 ± 34.8127.6 ± 28.7129.9 ± 30.4127.1 ± 49.1122.6 ± 54.1
Diastolic blood pressure (mmHg)73.2 ± 36.673.9 ± 32.472.1 ± 33.571.6 ± 39.169.1 ± 23.1
Heart rate (beats per minute)79.1 ± 19.874.4 ± 20.376.0 ± 23.380.1 ± 29.582.1 ± 31.9
Mitral valve prolapse, n (%)73 (1.7)1509 (1.7)428 (4.2)227 (12.3)167 (30.8)
Left atrial size (cm)
 AP3.7 ± 0.73.8 ± 0.74.4 ± 0.84.7 ± 0.84.8 ± 0.9
 SI5.0 ± 0.85.0 ± 0.85.7 ± 0.96.0 ± 1.06.2 ± 1.0
Right atrial length (cm)4.8 ± 0.74.9 ± 0.75.4 ± 0.95.6 ± 1.05.6 ± 1.1
Left ventricular dimension (cm)
 End diastole4.5 ± 0.64.6 ± 0.64.9 ± 0.95.3 ± 1.05.6 ± 1.0
 End systole2.8 ± 0.62.9 ± 0.63.3 ± 1.03.8 ± 1.24.0 ± 1.3
Left ventricular ejection fraction (%)57.2 ± 11.955.9 ± 12.546.2 ± 17.340.3 ± 20.041.1 ± 20.4
Right ventricular diastolic diameter (cm)3.3 ± 0.73.4 ± 0.83.7 ± 0.93.9 ± 0.94.0 ± 1.0
Peak transaortic velocity (m/s)1.5 ± 0.51.5 ± 0.51.8 ± 0.91.9 ± 1.11.8 ± 0.9
Transmitral peak E-wave velocity (m/s)0.8 ± 0.30.8 ± 0.31.0 ± 0.31.2 ± 0.41.3 ± 0.3
Transmitral peak A-wave velocity (m/s)0.8 ± 0.40.8 ± 0.30.8 ± 0.40.8 ± 0.50.8 ± 0.4
Transmitral E/A ratio1.1 ± 0.51.2 ± 0.51.3 ± 0.81.7 ± 0.91.9 ± 1.0
E/e′ ratio8.7 ± 3.69.1 ± 3.813.6 ± 6.415.9 ± 7.218.8 ± 9.7
Estimated peak tricuspid regurgitant pressure (mmHg)25.1 ± 10.025.9 ± 9.334.3 ± 11.839.7 ± 13.541.7 ± 14.2

Values are listed as means ± SDs unless otherwise indicated. P-values for all comparisons are < 0.001.

AP, anteroposterior dimension (measured on the parasternal long axis view); n, number; SD, standard deviation; SI, superoinferior dimension (measured in the apical four-chamber view).

Table 1

Baseline characteristics of individuals with mitral regurgitation (N = 104 851)

No MRMild (1+) MRModerate (2+) MRModerate to severe (3+) MRSevere (4+) MR
(N = 4431)(N = 87 908)(N = 10 130)(N = 1839)(N = 543)
Age (years)57.2 ± 17.957.8 ± 18.072.7 ± 14.674.1 ± 14.571.3 ± 15.6
Female, n (%)2166 (48.9)45457 (51.7)5432 (53.6)1021 (55.5)277 (51.0)
Bedside study, n (%)1392 (31.4)19079 (21.7)3326 (36.4)670 (36.4)233 (42.9)
Inpatient study, n (%)2373 (53.6)37381 (42.5)6323 (62.4)1295 (70.4)388 (71.5)
Suboptimal image quality, n (%)1016 (22.9)13467 (15.3)1599 (15.8)217 (11.8)57 (10.5)
Systolic blood pressure (mmHg)127.1 ± 34.8127.6 ± 28.7129.9 ± 30.4127.1 ± 49.1122.6 ± 54.1
Diastolic blood pressure (mmHg)73.2 ± 36.673.9 ± 32.472.1 ± 33.571.6 ± 39.169.1 ± 23.1
Heart rate (beats per minute)79.1 ± 19.874.4 ± 20.376.0 ± 23.380.1 ± 29.582.1 ± 31.9
Mitral valve prolapse, n (%)73 (1.7)1509 (1.7)428 (4.2)227 (12.3)167 (30.8)
Left atrial size (cm)
 AP3.7 ± 0.73.8 ± 0.74.4 ± 0.84.7 ± 0.84.8 ± 0.9
 SI5.0 ± 0.85.0 ± 0.85.7 ± 0.96.0 ± 1.06.2 ± 1.0
Right atrial length (cm)4.8 ± 0.74.9 ± 0.75.4 ± 0.95.6 ± 1.05.6 ± 1.1
Left ventricular dimension (cm)
 End diastole4.5 ± 0.64.6 ± 0.64.9 ± 0.95.3 ± 1.05.6 ± 1.0
 End systole2.8 ± 0.62.9 ± 0.63.3 ± 1.03.8 ± 1.24.0 ± 1.3
Left ventricular ejection fraction (%)57.2 ± 11.955.9 ± 12.546.2 ± 17.340.3 ± 20.041.1 ± 20.4
Right ventricular diastolic diameter (cm)3.3 ± 0.73.4 ± 0.83.7 ± 0.93.9 ± 0.94.0 ± 1.0
Peak transaortic velocity (m/s)1.5 ± 0.51.5 ± 0.51.8 ± 0.91.9 ± 1.11.8 ± 0.9
Transmitral peak E-wave velocity (m/s)0.8 ± 0.30.8 ± 0.31.0 ± 0.31.2 ± 0.41.3 ± 0.3
Transmitral peak A-wave velocity (m/s)0.8 ± 0.40.8 ± 0.30.8 ± 0.40.8 ± 0.50.8 ± 0.4
Transmitral E/A ratio1.1 ± 0.51.2 ± 0.51.3 ± 0.81.7 ± 0.91.9 ± 1.0
E/e′ ratio8.7 ± 3.69.1 ± 3.813.6 ± 6.415.9 ± 7.218.8 ± 9.7
Estimated peak tricuspid regurgitant pressure (mmHg)25.1 ± 10.025.9 ± 9.334.3 ± 11.839.7 ± 13.541.7 ± 14.2
No MRMild (1+) MRModerate (2+) MRModerate to severe (3+) MRSevere (4+) MR
(N = 4431)(N = 87 908)(N = 10 130)(N = 1839)(N = 543)
Age (years)57.2 ± 17.957.8 ± 18.072.7 ± 14.674.1 ± 14.571.3 ± 15.6
Female, n (%)2166 (48.9)45457 (51.7)5432 (53.6)1021 (55.5)277 (51.0)
Bedside study, n (%)1392 (31.4)19079 (21.7)3326 (36.4)670 (36.4)233 (42.9)
Inpatient study, n (%)2373 (53.6)37381 (42.5)6323 (62.4)1295 (70.4)388 (71.5)
Suboptimal image quality, n (%)1016 (22.9)13467 (15.3)1599 (15.8)217 (11.8)57 (10.5)
Systolic blood pressure (mmHg)127.1 ± 34.8127.6 ± 28.7129.9 ± 30.4127.1 ± 49.1122.6 ± 54.1
Diastolic blood pressure (mmHg)73.2 ± 36.673.9 ± 32.472.1 ± 33.571.6 ± 39.169.1 ± 23.1
Heart rate (beats per minute)79.1 ± 19.874.4 ± 20.376.0 ± 23.380.1 ± 29.582.1 ± 31.9
Mitral valve prolapse, n (%)73 (1.7)1509 (1.7)428 (4.2)227 (12.3)167 (30.8)
Left atrial size (cm)
 AP3.7 ± 0.73.8 ± 0.74.4 ± 0.84.7 ± 0.84.8 ± 0.9
 SI5.0 ± 0.85.0 ± 0.85.7 ± 0.96.0 ± 1.06.2 ± 1.0
Right atrial length (cm)4.8 ± 0.74.9 ± 0.75.4 ± 0.95.6 ± 1.05.6 ± 1.1
Left ventricular dimension (cm)
 End diastole4.5 ± 0.64.6 ± 0.64.9 ± 0.95.3 ± 1.05.6 ± 1.0
 End systole2.8 ± 0.62.9 ± 0.63.3 ± 1.03.8 ± 1.24.0 ± 1.3
Left ventricular ejection fraction (%)57.2 ± 11.955.9 ± 12.546.2 ± 17.340.3 ± 20.041.1 ± 20.4
Right ventricular diastolic diameter (cm)3.3 ± 0.73.4 ± 0.83.7 ± 0.93.9 ± 0.94.0 ± 1.0
Peak transaortic velocity (m/s)1.5 ± 0.51.5 ± 0.51.8 ± 0.91.9 ± 1.11.8 ± 0.9
Transmitral peak E-wave velocity (m/s)0.8 ± 0.30.8 ± 0.31.0 ± 0.31.2 ± 0.41.3 ± 0.3
Transmitral peak A-wave velocity (m/s)0.8 ± 0.40.8 ± 0.30.8 ± 0.40.8 ± 0.50.8 ± 0.4
Transmitral E/A ratio1.1 ± 0.51.2 ± 0.51.3 ± 0.81.7 ± 0.91.9 ± 1.0
E/e′ ratio8.7 ± 3.69.1 ± 3.813.6 ± 6.415.9 ± 7.218.8 ± 9.7
Estimated peak tricuspid regurgitant pressure (mmHg)25.1 ± 10.025.9 ± 9.334.3 ± 11.839.7 ± 13.541.7 ± 14.2

Values are listed as means ± SDs unless otherwise indicated. P-values for all comparisons are < 0.001.

AP, anteroposterior dimension (measured on the parasternal long axis view); n, number; SD, standard deviation; SI, superoinferior dimension (measured in the apical four-chamber view).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close